Android app on Google Play

Abbott Labs (ABT) Q3 Beats on Bottom Line, Misses on Top; Raises Low End of FY10 Outlook

October 20, 2010 7:46 AM EDT Send to a Friend
Abbott Labs (NYSE: ABT) Reports Q3 operating EPS of $1.05, 1 cent better than the analyst estimate of $1.04. Revenue for the quarter was $8.675 billion, which compares to the estimate of $8.91 billion.

Raises low end of its prior FY10 guidance range: from $4.13-$4.18 to $4.16-$4.18, vs. the consensus of $4.16.




You May Also Be Interested In


Related Categories

Earnings, Guidance, Hot List

Add Your Comment